Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02013219
Brief Title: A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)

First Submitted : December 11, 2013
First Submitted that Met QC Criteria : December 16, 2013
First Posted : December 17, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : November 12, 2019
Last Update Posted : November 14, 2019